RAND
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, RAND sits in the top decile of US sponsors by registered trial count (#283 of 15,742 sponsors by registered trial count).
RAND: 78 sponsored US clinical trials, 6 recruiting.
RAND sponsors 78 registered US clinical trials on ClinicalTrials.gov, 6 of them currently recruiting, and 66 completed. 0 of these trials are in Phase 3-4 (later-stage) and 11 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 3 trials.
Top-decile sponsor footprint
RAND ranks in the top decile of sponsors by registered trial count (#283 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
66 of 69 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (95.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
78 total, page 1 of 2
Families Left Behind
NCT06854757
Effectiveness of Brief Intervention in Primary Care for Diverse Young People (Chat)
NCT06699251
Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder
NCT06827288
Community Care Intervention to Decrease COVID-19 Vaccination Inequities
NCT06156254
Suicide Intervention for Alaska Native Youth
NCT05360888
Testing ALERT With GTO in Middle Schools
NCT05219422
Building Experience for Treating Trauma and Enhancing Resilience (BETTER)
NCT05330442
Delivering Church-based Interventions to Reduce Stigma and Mental Health Treatment Disparities Among Latinos
NCT03631745
The Impact of Virtual Doula Services on Birth Outcomes in Rural Communities
NCT07293741
Pilot of Training on 988 and Narcan
NCT07072819
The Impact of Standardized Tobacco Product Packaging on Young Adults in the Retail Environment
NCT05973981
HIV Provider Intervention to Address Intersectional Stigma and Medical Mistrust
NCT05803720
Testing Legally Feasible Options Studies 2/3
NCT05604508
Brief Online Intervention for Veterans
NCT04244461
Competitive Revision for CLARO: Collaboration Leading to Addiction Treatment and Recovery From Other Stresses
NCT04634279
Postoperative Nudges to Reduce Opioid Prescribing
NCT05070338
Measuring Chronic Pain Impact: Measurement Enhancement for Chronic Pain
NCT04426812
The Impact of Telelactation Services on Breastfeeding Outcomes
NCT04856163
Mental and Physical Well-Being of Frontline Health Care Workers During Coronavirus Disease 2019 (COVID-19)
NCT04723576
A Social Network AOD Intervention for Homeless Youth Transitioning to Housing
NCT04637815
Still Climbin': An Intervention to Improve Coping Among Black Sexual Minority Men
NCT04587869
Collaboration Leading to Addiction Treatment and Recovery From Other Stresses
NCT04559893
Substance Use Treatment and Recovery Team (START)
NCT04314648
TACUNA (Traditions and Connections for Urban Native Americans)
NCT04617938
Shrinking the Size of the Tobacco Power Wall
NCT04632030
Beyond Bias - Reducing Provider Bias Towards Adolescents to Increase Contraception Take-Up in Tanzania, Burkina Faso, and Pakistan
NCT04802304
A Randomized Controlled Trial of AppS to Home Monitor Your Asthma
NCT04401332
A Cognitive Behavioral Therapy Group Intervention to Increase HIV Testing and PrEP Use Among Latinx Sexual Minority Men
NCT04225832
Testing Legally Feasible Options: Study 1
NCT04259749
Text Messaging-Based Smoking Cessation Program for Homeless Youth
NCT03874585
Linking Churches With Parks to Increase Physical Activity Among Latinos
NCT03858868
Interventions to Improve Reproductive Health Among Adolescents
NCT04227236
Intervention for Substance Use and Sexual Risk Behavior in Homeless Youth
NCT03735784
Trauma-informed Collaborative Care for Low-income African Americans With PTSD
NCT03591107
A Pilot Intervention to Improve Coping With Discrimination and Adherence Among HIV-Positive Latino MSM
NCT03432819
A Randomized Controlled Trial of an Antiretroviral Treatment Adherence Intervention for HIV+ African Americans
NCT03331978
Using Mobile Technology and Incentives With Men Who Have Sex With Men and Transgender Women for HIV Prevention
NCT03144336
Patient Engagement Via Crowdsourcing
NCT03264521
Community-Partnered Participatory Development of Mobile Interventions
NCT02986945
Expanding Rural Access to Breastfeeding Support Via Telehealth: The Tele-MILC Trial
NCT02870413
Enhancing Housing First Programs With a Social Network Substance Use Intervention
NCT02140359
Online Program for Young Adult Veteran Drinkers
NCT02187887
Supporting Treatment Adherence Readiness Through Training (START)
NCT02329782
Web Intervention for Concerned Partners to Prevent Service Member Alcohol Abuse Abuse
NCT02073825
RCT of the Restorative Practices Intervention
NCT02155296
Assessment of Chiropractic Treatment Using Reaction and Response Times in Members of the Special Operation Forces (ACT2)
NCT02168153
Motivational Interviewing and Culture for Urban Native American Youth (MICUNAY)
NCT02290938
Integrated Collaborative Care for Substance Use Disorders
NCT01810159
Substance Use and Sexual Risk Reduction Intervention for Homeless Youth
NCT02188797
Preparing to Run Effective Prevention
NCT02135991
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 7 |
| Phase 2 | 4 |
Therapeutic Areas
What is open in the RAND pipeline
6 recruiting of 78 indexed (8% open); 66 completed (85%).
Phase mix: 0 late (III/IV) vs 11 early (I/II) (early-phase heavy).
Top condition: Depression (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
RAND: open-pipeline peers nationwide
Peers matched on 78 registered trials and 8% open enrollment, not the therapeutic-area sidebar.
RAND sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 78 trials (± recruiting share)
- Actavis · 79 trials · 0% recruiting
- University of Hawaii · 77 trials · 17% recruiting
- U.S. Army Medical Research and Development Command · 77 trials · 4% recruiting
- BioMarin Pharmaceutical · 80 trials · 16% recruiting
Sponsors near 8% open enrollment (± trial volume)
- Alumis · 8% recruiting · 13 trials
- Andrei Iagaru · 8% recruiting · 13 trials
- BioXcel Therapeutics · 8% recruiting · 13 trials
- Corporal Michael J. Crescenz VA Medical Center · 8% recruiting · 13 trials
Related
What to do with this RAND page
78 registered trials is a research-attention snapshot, not an endorsement of RAND or any single study.
- 6 of RAND's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition RAND studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
RAND pipeline card: 78 registered trials from official public datasets.Report a data error.